Baseline characteristics n (%) | Total (n = 362) | Intervention (n = 150) | Control (n = 212) | p-value | ASMD |
---|---|---|---|---|---|
Study site | Â | Â | Â | 0.002 | 0.299 |
 Study site 1 | 119 (32.9%) | 43 (28.7%) | 76 (35.8%) |  |  |
 Study site 2 | 98 (27.1%) | 31 (20.7%) | 67 (31.6%) |  |  |
 Study site 3 | 145 (40.1%) | 76 (50.7%) | 69 (32.5%) |  |  |
Age (years) | Â | Â | Â | Â | Â |
 Mean (SD) [Min, Max] | 63 (13) [19, 85] | 66 (13) [24, 85] | 62 (13) [19, 85] | 0.004 | 0.309 |
Sex | Â | Â | Â | 0.414 | 0.087 |
 Male | 219 (60.5%) | 87 (58.0%) | 132 (62.3%) |  |  |
 Female | 143 (39.5%) | 63 (42.0%) | 80 (37.7%) |  |  |
Family status | n = 333 | n = 124 | n = 209 | 0.171 | 0.186 |
 Married | 226 (67.9%) | 89 (71.8%) | 137 (65.6%) |  |  |
 Single | 44 (13.2%) | 18 (14.5%) | 26 (12.4%) |  |  |
 Divorced/Widowed | 63 (18.9%) | 17 (13.7%) | 46 (22.0%) |  |  |
Care level | n = 329 | n = 123 | n = 206 | 0.675 | 0.022 |
 None | 266 (80.9%) | 98 (79.7%) | 168 (81.6%) |  |  |
 Yes | 63 (19.1%) | 25 (20.3%) | 38 (18.4%) |  |  |
   Care level 1 | 7 (11.1%) | 4 (17%) | 3 (8%) |  |  |
 Care level 2 | 26 (41.3%) | 11 (46%) | 15 (38%) |  |  |
 Care level 3 | 21 (33.3%) | 6 (25%) | 15 (38%) |  |  |
 Care level 4 | 9 (14.3%) | 3 (13%) | 6 (15%) |  |  |
Time since diagnosis (months) | Â | Â | Â | Â | Â |
 Median (P25, P75) | 6 (2, 22) | 5 (1, 26) | 7 (2, 19) | 0.416 | 0.114 |
 < 12 months | 227 (62.7%) | 89 (59.3%) | 138 (65.1%) |  |  |
 12 – 60 months | 108 (29.8%) | 46 (30.7%) | 62 (29.2%) |  |  |
 > 60 months | 27 (7.5%) | 15 (10.0%) | 12 (5.7%) |  |  |
Diagnosis | Â | Â | Â | 0.013 | 0.247 |
 Acute leukemia | 69 (19.1%) | 19 (12.7%) | 50 (23.6%) |  |  |
 Aggressive lymphoma | 58 (16.0%) | 20 (13.3%) | 38 (17.9%) |  |  |
 Malignant neoplasm of bronchus and lung | 62 (17.1%) | 33 (22.0%) | 29 (13.7%) |  |  |
 Metastasized colorectal cancer | 78 (21.6%) | 34 (22.7%) | 44 (20.8%) |  |  |
 Malignant neoplasm of pancreas | 32 (8.8%) | 17 (11.3%) | 15 (7.1%) |  |  |
 Multiple myeloma and malignant plasma cell neoplasms | 24 (6.6%) | 6 (4.0%) | 18 (8.5%) |  |  |
 Metastasized malignant neoplasm of breast | 9 (2.5%) | 4 (2.7%) | 5 (2.4%) |  |  |
 Others | 30 (8.3%) | 17 (11.3%) | 13 (6.1%) |  |  |
Duration of living in Germany (years) | n = 332 | n = 125 | n = 207 | 0.762 | 0.050 |
 Since birth | 287 (86.5%) | 107 (85.6%) | 180 (87.0%) |  |  |
 < 5 years | 4 (1.2%) | 1 (0.8%) | 3 (1.4%) |  |  |
 ≥ 5 years | 41 (12.3%) | 17 (13.6%) | 24 (11.6%) |  |  |
Education | n = 336 | n = 125 | n = 211 | 0.003 | 0.323 |
 Low | 29 (8.6%) | 19 (15.2%) | 10 (4.7%) |  |  |
 Medium | 101 (30.1%) | 38 (30.4%) | 63 (29.9%) |  |  |
 High | 206 (61.3%) | 68 (54.4%) | 138 (65.4%) |  |  |
Financial Situation | n = 331 | n = 123 | n = 208 | 0.817 | 0.022 |
 Very good | 28 (8.5%) | 9 (7.3%) | 19 (9.1%) |  |  |
 Good | 173 (52.3%) | 65 (52.8%) | 108 (51.9%) |  |  |
 Moderate | 91 (27.5%) | 37 (30.1%) | 54 (26.0%) |  |  |
 Difficult | 28 (8.5%) | 9 (7.3%) | 19 (9.1%) |  |  |
 Very difficult | 11 (3.3%) | 3 (2.4%) | 8 (3.8%) |  |  |
Subjective Social Status (MacArthur Scale) | n = 314 | n = 122 | n = 201 |  |  |
 Mean (SD) | 6.3 (1.5) | 6.1 (1.4) | 6.4 (1.5) | 0.055 | 0.223 |
Social support (OSSS-3) | n = 332 | n = 124 | n = 208 |  |  |
 Mean (SD) | 11.0 (2.1) | 10.8 (2.1) | 11.1 (2.1) | 0.300 | 0.118 |
 Poor (3 – 8) | 35 (10.5%) | 15 (12.1%) | 20 (9.6%) |  |  |
 Moderate (9 – 11) | 158 (47.6%) | 60 (48.4%) | 98 (47.1%) |  |  |
 Strong (12 – 14) | 139 (41.9%) | 49 (39.5%) | 90 (43.3%) |  |  |